Raw vector
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:HCVSS and EPSS are reproduced from their sources (NVD, FIRST EPSS). Risk Priority is our own derived reading, not an NVD score.
Summary
CVE-2023-20229 is a high-severity Path Traversal (CWE-22) vulnerability in Cisco Duo Device Health Application. Its CVSS base score is 7.1 (High).
Operationally, exploitation aligns with the MITRE ATT&CK technique Data Obfuscation (T1001); ranked at the 34th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
OWASP Top 10 for Web (2025)
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-24408
Vulnerability Data
A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due…
more
to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise Techniques
CVEs Like This One
Affected Assets
Mitigating Controls
Control response
—
—
—
V5.3.2
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Validates pathnames and filenames to prevent traversal outside intended directories.
Mitigating Controls (NIST CSF 2.0) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→CSF cross-walk (authority under review) — links open the control.
Patching/maintenance can remediate known path-traversal flaws in deployed software (partial prevention of exploitability) but does nothing to stop the coding defect from being introduced in the first place.
PR.AA-05 defines and reviews access policies but does not address code-level pathname neutralization, so neither direction prevents CWE-22.
Mitigating Controls (ISO/IEC 27001:2022 Annex A) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→ISO cross-walk (authority under review) — links open the control.